COYA
Coya Therapeutics, Inc. Common Stock
NASDAQ: COYA · HEALTHCARE · BIOTECHNOLOGY
$4.07
-4.46% today
Updated 2026-04-29
Market cap
$95.47M
P/E ratio
—
P/S ratio
12.02x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $8
Volume
0.1M
Coya Therapeutics, Inc. Common Stock (COYA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-14.9%
Last 4 quarters
Revenue YoY growth
+202768.8%
Most recent quarter
EPS YoY growth
-51.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-0.8%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-24 | $-0.27 | +58.0% | $4.22 | $4.20 | -0.6% |
| 2025-11-12 | $-0.13 | +78.0% | $6.01 | $5.96 | -0.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.65 | $-0.27 | +58.0% | $3.96M | +202768.8% |
| 2025-09-30 | $-0.59 | $-0.13 | +78.0% | $3.56M | — |
| 2025-06-30 | $0.13 | $-0.36 | -376.9% | $163616.00 | -95.2% |
| 2025-03-31 | $-0.46 | $-0.44 | +4.3% | $257884.00 | +103.3% |
| 2024-12-31 | $-0.40 | $-0.18 | +55.0% | $1952.00 | -100.0% |
| 2024-09-30 | $-0.36 | $-0.26 | +27.8% | — | — |
| 2024-06-30 | $0.23 | $-0.19 | -182.6% | $3.43M | — |
| 2024-03-31 | $-0.29 | $-0.35 | -20.7% | $126838.00 | — |
| 2023-12-31 | $0.26 | $0.28 | +7.7% | $6.00M | — |
| 2023-09-30 | $-0.37 | $-0.48 | -29.7% | — | — |
| 2023-06-30 | $-0.32 | $-0.31 | +3.1% | — | — |
| 2023-03-31 | $-0.43 | $-0.28 | +34.9% | — | — |
Frequently asked questions
Has Coya Therapeutics, Inc. Common Stock beaten earnings estimates?
Coya Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -14.9% over the last 4 quarters.
How does COYA stock react to earnings?
COYA stock has moved an average of -0.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Coya Therapeutics, Inc. Common Stock's revenue growth rate?
Coya Therapeutics, Inc. Common Stock reported year-over-year revenue growth of +202768.8% in its most recent quarter, with EPS growing -51.5% year-over-year.